• 1
    Nordmann R, Ribière C, Rouach H. Implication of free radical mechanisms in ethanol induced cellular injury. Free Rad Biol Med 1992; 12: 219240.
  • 2
    Lettèron P, Duchatelle V, Berson A, Fromenty B, Degott C, Benhaumou JP, Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut 1993; 34: 409414.
  • 3
    Lecomte E, Herberth B, Pirrolet P, Chancerelle Y, Arnaud J, Musse N, Faille F, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994; 60: 255261.
  • 4
    Clot P, Tabone M, Aricò S, Albano E. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 1994; 35: 16371643.
  • 5
    Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 448453.
  • 6
    French SW, Wong K, Jui L, Albano E, Hagbjörk A-L, Ingelman-Sundberg M. Effect of ethanol on cytochrome P4502E1 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 1993; 58: 6175.
  • 7
    Morimoto M, Hagbjork A-L, Nanji AA, Ingelman-Sundberg M, Lindros K, Fu PC, Albano E, et al. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 1993; 10: 459464.
  • 8
    Sadrzadeh HSM, Nanji AA, Price PL. The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats. J Pharmacol Exp Ther 1994; 269: 632636.
  • 9
    Nanji AA, Khwaja S, Tahan SR, Sadrzadeh HSM. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 1994; 269: 12801285.
  • 10
    Morimoto M, Hagbjork A-L, Wan YJY, Fu PC, Ingelman-Sundberg M, Albano E, Clot P, et al. Modulation of alcoholic liver disease by cytochrome P4502E1 inhibitors. Hepatology 1995; 21: 16101617.
  • 11
    Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact 1988; 65: 223234.
  • 12
    Albano E, Tomasi A, Goria-Gatti L, Persson JO, Terelius Y, Ingelman-Sundberg M, Dianzani MU. Role of ethanol-inducible cytochrome P-450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol 1991; 41: 18951902.
  • 13
    Albano E, Parola M, Comoglio A, Dianzani MU. Evidence for the covalent binding of hydroxyethyl radicals to rat liver microsomal proteins. Alcohol Alcohol 1993; 28: 453459.
  • 14
    Moncada C, Torres V, Vargese E, Albano E, Israel Y. Ethanol-derived immunoreactive species formed by free radical mechanisms. Mol Pharmacol 1994; 46: 786791.
  • 15
    Clot P, Bellomo G, Tabone M, Aricò S, Albano E. Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroentrology 1995; 108: 201207.
  • 16
    Tsukamoto H, Reidelberger RD, French SW, Largman C. Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol 1984; 247: R595R599.
  • 17
    Ekström G, Von Bahr C, Ingelman-Sundberg M. Human liver cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. Biochem Pharmacol 1989; 38: 689693.
  • 18
    Albano E, Tomasi A, Ingelman-Sundberg M. Spin trapping of alcohol-derived radicals in microsomes and reconstituted systems by electron spin resonance. Methods Enzymol 1994; 233: 117127.
  • 19
    Esterbauer H, Lang J, Zadravec S, Slater TF. Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 1984; 105: 319325.
  • 20
    Comiacini M, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, Scuro LA, et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 1991; 32: 349358.
  • 21
    Knecht KT, Thurman RG, Mason RP. Role of superoxide and trace transition metals in the production of α-hydroxyethyl radical from ethanol by microsomes from alcohol dehydrogenasedeficient deermice. Arch Biochem Biophys 1993; 303: 339348.
  • 22
    Knecht KT, Bradfort BU, Mason RP, Thurman RG. In vivo formation of free radical metabolite of ethanol. Mol Pharmacol 1990; 38: 2630.
  • 23
    Moore DR, Reinke LA, McCay PB. Metabolism of ethanol to 1-hydroxyethyl radicals in vivo: detection with intravenous administration of α-(4-pyridyl-1-oxide)N-t-butylnitrone. Mol Pharmacol 1995; 47: 12241230.
  • 24
    Knecht KT, Adachi Y, Bradfort BU, Limuro Y, Kadiiska M, Qun-Hui X, Thurman RG. Free radical adducts in the bile of ras treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells. Mol Pharmacol 1995; 47: 10281034.
  • 25
    Clot P, Ingelman-Sundberg M, Bellomo G, Tabone M, Arico S, Israel Y, Moncada C, et al. Detection of antibodies against CYP2E1 modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis [Abstract]. Hepatology 1994; 20: 317A.
  • 26
    Persson JO, Terelius Y, Ingelman-Sundberg M. Cytochrome P450-dependent formation of oxygen radicals. Isoenzyme-specific inhibition of P450-mediated reduction of oxygen radicals and carbon tetrachloride. Xenobiotica 1990; 20: 887900.
  • 27
    Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC, Largman C. Severe and progressive statosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 1985; 5: 224232.
  • 28
    Tsukamoto H, Towner SJ, Ciofalo LM, French SW. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 1986; 6: 814822.
  • 29
    Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994; 20: 453460.
  • 30
    Niemelä O, Parkkila S, Yiä-Herttuala S, Halsted C, Witztum JL, Lanca A, Israel Y. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994; 70: 537546.
  • 31
    Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR, Waxman DJ. Markedly enhanced cytochrome P4502E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-treated ethanol-fed rats. Alcohol Clin Exp Res 1994; 18: 12801285.
  • 32
    Nicholls R, De Jersey J, Worral S, Wilce P. Modification of proteins and other biological molecules by acetaldehyde: adduct structure and functional significance. Int J Biochem 1992; 24: 18991906.
  • 33
    Israel Y, Hurwitz E, Niemela O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containingepitopes in ac-etaldehyde-protein adducts. Proc Natl Acad Sci U S A 1986; 83: 79237927.
  • 34
    Worrall S, De Jersey J, Shanley BC, Wilce PA. Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats. Alcohol Alcohol 1989; 24: 217223.
  • 35
    Niemela O, Klajner F, Orrego H, Vidinis E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987; 7: 12101214.
  • 36
    Hoerner M, Beherens UJ, Worner TM, Blacksberg I, Braly LF, Shaffner F, Lieber CS. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 8: 569574.
  • 37
    Koskinas J, Kenna JG, Bird GL, Alexander GJM, Williams R. Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology 1992; 103: 18601867.
  • 38
    Tuma DJ, Klassen LW. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 1992; 103: 19691973.
  • 39
    McFarlane IG. Autoimmunity in liver disease. Clin Sci 1984; 67: 569587.
  • 40
    Yokoyama H, Ishii H, Nagata S, Kato S, Kamegaya K, Tsuchiya M. Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts. Hepatology 1993; 17: 1419.
  • 41
    Yokoyama H, Nagata S, Moriya S, Kato S, Ito K, Kamegaya K, Ishii H. Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts. Hepatology 1995; 21: 14381442.
  • 42
    Worral S, De Jersey J, Shanley BC, Wilce PA. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects. Alcohol Alcohol 1990; 25: 509517.